Standout Papers

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer 2023 2026 202476
  1. Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer (2023)
    Charles M. Rudin, Martin Reck et al. Journal of Hematology & Oncology

Immediate Impact

36 standout
Sub-graph 1 of 18

Citing Papers

Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2025 Standout
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics
2025 Standout
2 intermediate papers

Works of Amanda Goldrick being referenced

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma
2020
Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures
2016

Author Peers

Author Last Decade Papers Cites
Amanda Goldrick 154 36 28 79 43 10 223
Eamonn O’Brien 127 8 41 87 19 12 285
Hans Strauß 83 48 50 59 45 12 268
Sreekanth Reddy 165 44 16 67 90 11 264
Nicholas C. Richardson 89 21 39 60 15 16 235
Bhuvana Srinivasan 78 7 15 54 26 15 170
Shuai Wang 89 10 57 97 120 14 288
Michael Korn 164 20 52 58 62 17 254
Siddharth Kunte 120 24 9 63 51 12 216
M. H. Le 136 31 25 91 52 9 265
Şeyda Gündüz 180 6 44 31 74 15 243

All Works

Loading papers...

Rankless by CCL
2026